Zephyr Health grabs $17.5M with infusion from Google Ventures


Zephyr Health, an up-and-coming health data company, has just completed a new funding round of $17.5 million with the lead investment coming from Google Ventures. The company to date has raised $33.5 million, including participation from investors Kleiner Perkins Caufield & Byers and Icon Ventures.

The company collects data via its Illuminate solution from multiple sources (epidemiology data, sales and profile data for healthcare providers (HCPs), and hospitals according to Zephyr’s website) in order to better inform health professionals on appropriate treatment regimens for patients. The data can also be used to measure which drugs and products are more popular by region and to adjust their sales strategies accordingly with predictive analytics. Their data sync can also integrate with other office organizing software like Salesforce and Oracle according to the company.

Google Ventures increases focus on Health Startups

Google Ventures touts having invested in over 300 companies, comprising a very diverse portfolio up to this point. According to the VC’s website they have “a unique focus on machine learning and life science investing.” The health section of GV’s portfolio jumped from the smallest to largest recipient of its funds between 2012 and 2014. That shift might be reflected in the growth of Google’s Life Sciences division in 2013, which could be poised for more growth following the corporate shakeup that gave birth to Alphabet Inc. two weeks ago.

The health section of that investment strategy is hearty. The VC lists Bill Maris, Krishna Yeshwant, Blake Byers, Scott Davis, Anthony Philippakis and Ben Robbins among its top investing partners. GV has invested in genetics startup 23andme, oncology data company Flatiron, genomic treatment firm Editas Medicine and several more. Flatiron itself has been the recipient of $100 million in Google Ventures investments.

Zephyr counts Genentech, Gilead, Medtronic, Onyx and Amgen among its corporate clients.

The company was founded in 2011 by CEO William King. While the company has its headquarters in San Francisco, they maintain offices in London and Pune, India.


Please enter your comment!
Please enter your name here